Nneɛma pii na ebetumi ama obi anya asikreyare, ebi ne:
1. Abusua mu kokoram: Sɛ obi maame anaa ne papa anaa ne nua bi wɔ asikreyare a, ebetumi ama wanya bi.
2. Mfe a obi adi: Sɛ obi nyin a, ɛyɛ den sɛ obenya type 2 asikreyare, titiriw bere a wadi mfe 45 ne akyi.
3. Sɛnea wo mu duru te: Sɛ wo mu duru boro so anaa woayɛ kɛse dodo a, ebetumi ama woayare.
4. Apɔw mu a wonteɛteɛ: Apɔw mu a wonteɛteɛ betumi ama woayare.
5. Abusuakuw anaa abusua a obi fi mu: Nnipa bi te sɛ Afrikafo, Hispanicfo, Amerikafo a wofi Asia, ne Asiafo na wɔn mu pii taa nya type 2 asikreyare.
6. Nyinsɛn mu asikreyare: Mmea a wɔanyinsɛn na wonya asikreyare no betumi anya type 2 asikreyare bere a wɔanyinyin no.
7. Polycystic ovary syndrome: Mmea a wɔwɔ saa yare yi mu no betumi anya type 2 asikreyare.
8. Aduan a Ɛkeka Obi Ho Yare: Saa yare yi a ebi ne mogya mmoroso, mogya mu srade pii, ne sisi kɛse no ma obi nya asikreyare a ɛto so abien.
9. Sigaretnom: Sigaretnom betumi ama obi anya asikreyare a wɔfrɛ no type 2 diabetes.
10. Asikreyare a ɛwɔ obi mu: Sɛ obi wɔ asikreyare a ɛwɔ ne mu a, ebetumi ama wanya type 2 asikreyare.
11. Awo mu a wɔawo abofra a ne mu nyɛ duru: Sɛ wɔwo abofra a ne mu nyɛ duru a, ebetumi ama wanya type 2 asikreyare.
12. Mogya mmoroso: Sɛ obi mogya mmoroso a, ɛma otumi nya asikreyare a wɔfrɛ no type 2 no bi.
13. Kokoram ne srade a ɛwɔ mogya mu a ɛboro so: Sɛ srade a ɛwɔ mogya mu dɔɔso na HDL (nea eye) a ɛwɔ mogya mu no so tew a, ɛma obi nya asikreyare a wɔfrɛ no type 2.
14. Nna mu home a ɛmma obi ntumi nhome yiye: Sɛ obi da na n'ahome no so tew a, ebetumi ama wanya type 2 asikreyare.
15. Adwennwene: Adwennwene a enni sabea betumi ama obi anya asikreyare a wɔfrɛ no type 2.
16. Nnuru bi: Nnuru bi te sɛ steroid ne nnuru a wɔde siw adwenemhaw ano betumi ama obi anya type 2 asikreyare.
17. Akɔnɔ: Akɔnɔ a enni sabea betumi ama obi anya asikreyare a wɔfrɛ no type 2 no bi.
18. Sɛ obi nteɛteɛ n'apɔw mu: Sɛ obi nteɛteɛ n'apɔw mu a, ebetumi ama wanya type 2 asikreyare.
19. Sodi a srade ne ahoɔden pii wom: Sodi a srade ne ahoɔden pii wom betumi ama obi anya type 2 asikreyare.
20. Asanom: Asanom ntraso betumi ama obi anya asikreyare a wɔfrɛ no type 2 no bi.
21. Nna a wɔhwere: Sɛ obi nna sɛnea ɛsɛ a, ebetumi ama wanya type 2 asikreyare.
22. Mframa a wɔsɛe no: Mframa a wɔsɛe no betumi ama obi anya asikreyare a wɔfrɛ no type 2 no bi.
23. Nyarewa bi: Nyarewa bi te sɛ hepatitis C betumi ama obi anya type 2 asikreyare.
24. Homocysteine a ɛwɔ mogya mu pii: Amino acid a wɔfrɛ no homocysteine a ɛwɔ mogya mu pii no betumi ama obi anya type 2 asikreyare.
25. Uric acid a ɛwɔ obi mu dɔɔso: Sɛ uric acid a ɛwɔ obi mu dɔɔso a, ebetumi ama wanya type 2 asikreyare.
26. C-reactive protein a ɛwɔ ahoɔden kɛse: C-reactive protein a ɛwɔ ahoɔden kɛse, a ɛyɛ ade a ɛma obi ho honhon no betumi ama obi anya type 2 asikreyare.
27. Fibrinogen a ɛwɔ mogya mu pii: Fibrinogen, protein a mogya tumi keka a ɛwɔ mogya mu pii no betumi ama obi anya asikreyare a ɛto so abien.
28. PAI-1 a ɛwɔ mogya mu pii: PAI-1, a ɛyɛ mogya a ɛboa ma mogya yɛ den no, a ɛwɔ mogya mu pii no betumi ama obi anya asikreyare a ɛto so abien.
29. Leptin a ɛwɔ nipadua mu pii: Leptin a ɛwɔ nipadua mu pii no betumi ama obi anya type 2 asikreyare.
30. Resistin a ɛwɔ ahoɔden kɛse: Resistin, hormone a ɛma obi ntumi nnyina insulin ano no, a ɛwɔ ahoɔden kɛse no betumi ama obi anya
King WM, Saseen JJ, Anderson SL: Characterization of diabetes risk factors in patients prescribed chronic statin therapy. Ther Adv Chronic Dis. 2014, 5 (5): 206-11.
Bielinski SJ, Pankow JS, Rasmussen-Torvik LJ, Bailey K, Li M, Selvin E, Couper D, Vazquez G, Brancati F: Strength of association for incident diabetes risk factors according to diabetes case definitions: the Atherosclerosis Risk in Communities Study. Am J Epidemiol. 2012, 175 (5): 466-72.
Gangwisch JE, Gross R, Malaspina D: Differential Associations Between Depression, Risk Factors for Insulin Resistance and Diabetes Incidence in a Large U.S. Sample. Isr J Psychiatry Relat Sci. 2015, 52 (2): 85-90.
Leiva AM, Martínez MA, Petermann F, Garrido-Méndez A, Poblete-Valderrama F, Díaz-Martínez X, Celis-Morales C: [Risk factors associated with type 2 diabetes in Chile]. Nutr Hosp. 2018, 35 (2): 400-407.
Chatterjee R, Maruthur NM, Edelman D: Novel Risk Factors for Type 2 Diabetes in African-Americans. Curr Diab Rep. 2015, 15 (12): 103.
Higa S, Maesato A, Ishigaki S, Suenari K, Chen YJ, Chen SA: Diabetes and Endocrine Disorders (Hyperthyroidism/Hypothyroidism) as Risk Factors for Atrial Fibrillation. Card Electrophysiol Clin. 2021, 13 (1): 63-75.
Brodalko B: [Diabetes risk factors in the Regional Railway Hospital in Lublin, described on the basis of medical documentation]. Wiad Lek. 2000, 53 (5-6): 255-61.
['Nsɛm a Ɛnsɛ sɛ Wɔka:']
['Wɔayɛ wɛbsaet yi sɛ wɔmfa nkyerɛkyerɛ na wɔmfa nkyerɛkyerɛ afoforo, na ɛnyɛ sɛ wɔde rema aduruyɛ ho afotu anaa wɔde rema adwuma.']
['Ɛnsɛ sɛ wɔde nsɛm a wɔde ama no di dwuma de hwehwɛ yare bi ho yare anaa wɔde sa yare, na ɛsɛ sɛ wɔn a wɔrehwehwɛ ayaresa ho afotu no kohu oduruyɛfo a ɔwɔ tumi krataa.']
['Yɛsrɛ wo hyɛ no nsow sɛ, sɛnea wɔhwɛ nsɛmmisa no so no, sɛ ɛba sɛ wɔrekyerɛw nnipa dodow a wɔanya yare bi ho asɛm a, ɛntaa nsi yiye.']
['Hwehwɛ afotu fi wo duruyɛfo anaa ɔyaresafo foforo a ɔfata hɔ bere biara wɔ yare bi ho. Nnya adwene sɛ wo nsa bɛka oduruyɛfo afotu anaasɛ wubetwa so esiane biribi a woakenkan wɔ wɛbsaet yi so nti. Sɛ wususuw sɛ ebia wo ho behia wo wɔ ayaresa mu a, frɛ 911 anaa kɔ ayaresabea a ɛbɛn wo paa ntɛm ara.']
['Nsɛm a wɔmmɔ ho ban:']
['Digital Millennium Copyright Act a wɔhyɛe wɔ afe 1998 mu, 17 U.S.C. § 512 (DMCA) no ma wɔn a wɔwɔ hokwan sɛ wɔyɛ wɔn nneɛma no kwan sɛ wɔyɛ nea wɔpɛ biara.']
["Sɛ wugye di sɛ nsɛm anaa nneɛma a ɛwɔ yɛn wɛbsaet anaa yɛn dwumadibea no mu bi to wo mmara a wode bɔɔ nneɛma ho ban no a, wo (anaa w'ananmusifo) betumi de krataa akɔma yɛn de aka sɛ yɛnyi nsɛm anaa nneɛma no, anaa yɛmmɔ kwan mma wonnya bi."]
["Ɛsɛ sɛ wɔde krataa ne email na ɛbɔ amanneɛ (hwɛ 'Contact' afã hɔ na wubehu email address)."]
['DMCA hwehwɛ sɛ wo amanneɛbɔ a ɛfa nea wɔkyerɛ sɛ ɛyɛ mmara a wobu so ho no de nsɛm a edidi so yi ka ho: (1) adwuma a mmara bɔ ho ban a wɔkyerɛ sɛ wɔadi so no ho asɛm; (2) nsɛm a wɔkyerɛ sɛ wɔadi so no ho asɛm ne nsɛm a ɛbɛboa yɛn ma yɛahu baabi a ɛwɔ; (3) wo ho nsɛm a yɛde bedi nkitaho, a wo address, telefon nɔma ne email address ka ho; (4) wo nsɛm a ɛkyerɛ sɛ wugye di sɛ nea wɔabɔ ho sobo no nyɛ nea mmara ma ho kwan; ']
['(5) wo nsahyɛ a ɛkyerɛ sɛ nsɛm a ɛwɔ amanneɛbɔ no mu yɛ nokware, na wowɔ tumi sɛ wode nea wɔkyerɛ sɛ woadi ho dwuma no bedi dwuma; ']
['ne (6) nea ɔwɔ tumi sɛ ɔyɛ biribi ma obi a ɔwɔ tumi sɛ ɔyɛ biribi ma no no nsaano nkyerɛwee.']
['Sɛ woamfa nsɛm a yɛaka yi nyinaa anka ho a, ebetumi ama wo ka no akyɛ.']
['Nkitahodi']
['Yɛsrɛ wo, fa nsɛmmisa anaa nyansahyɛ biara a wowɔ brɛ yɛn wɔ e-mail so.']
What are the risk factors for diabetes?
There are several risk factors for diabetes, including:
1. Family history: Having a parent or sibling with diabetes increases your risk.
2. Age: The risk of type 2 diabetes increases as you get older, especially after age 45.
3. Weight: Being overweight or obese increases your risk.
4. Physical inactivity: Lack of exercise can increase your risk.
5. Race or ethnicity: Certain ethnic groups, such as African Americans, Hispanic Americans, Native Americans, and Asian Americans, have a higher risk of developing type 2 diabetes.
6. Gestational diabetes: Women who have had gestational diabetes during pregnancy are at higher risk of developing type 2 diabetes later in life.
7. Polycystic ovary syndrome: Women with this condition have a higher risk of developing type 2 diabetes.
8. Metabolic syndrome: This cluster of conditions, including high blood pressure, high cholesterol, and large waist circumference, increases the risk of type 2 diabetes.
9. Smoking: Smoking can increase insulin resistance, which can lead to type 2 diabetes.
10. Prediabetes: Having prediabetes, or higher than normal blood sugar levels, increases the risk of developing type 2 diabetes.
11. Low birth weight: Babies with low birth weight have a higher risk of developing type 2 diabetes later in life.
12. High blood pressure: Having high blood pressure increases the risk of developing type 2 diabetes.
13. Abnormal cholesterol and triglyceride levels: High levels of triglycerides and low levels of HDL (good) cholesterol increase the risk of type 2 diabetes.
14. Sleep apnea: People with sleep apnea have an increased risk of developing type 2 diabetes.
15. Stress: Chronic stress can increase the risk of developing type 2 diabetes.
16. Certain medications: Some medications, such as steroids and antipsychotics, can increase the risk of developing type 2 diabetes.
17. Inflammation: Chronic inflammation can increase the risk of developing type 2 diabetes.
18. Sedentary lifestyle: A sedentary lifestyle can increase the risk of developing type 2 diabetes.
19. High-fat, high-calorie diet: Consuming a diet high in unhealthy fats and calories can increase the risk of developing type 2 diabetes.
20. Alcohol consumption: Excessive alcohol consumption can increase the risk of developing type 2 diabetes.
21. Sleep deprivation: Inadequate sleep can increase the risk of developing type 2 diabetes.
22. Air pollution: Exposure to air pollution can increase the risk of developing type 2 diabetes.
23. Certain infections: Certain infections, such as hepatitis C, can increase the risk of developing type 2 diabetes.
24. High levels of homocysteine: High levels of homocysteine, an amino acid, can increase the risk of developing type 2 diabetes.
25. High levels of uric acid: High levels of uric acid, a waste product, can increase the risk of developing type 2 diabetes.
26. High levels of C-reactive protein: High levels of C-reactive protein, a marker of inflammation, can increase the risk of developing type 2 diabetes.
27. High levels of fibrinogen: High levels of fibrinogen, a protein involved in blood clotting, can increase the risk of developing type 2 diabetes.
28. High levels of PAI-1: High levels of PAI-1, a protein involved in blood clotting, can increase the risk of developing type 2 diabetes.
29. High levels of leptin: High levels of leptin, a hormone involved in appetite regulation, can increase the risk of developing type 2 diabetes.
30. High levels of resistin: High levels of resistin, a hormone involved in insulin resistance, can increase the risk of developing
Disclaimer: medical
This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.
The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.
Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.
Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.
Disclaimer: copyright
The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.
['Ɛfa ho']
['BioMedLib de kɔmputa a wɔde di dwuma (mfidie a wɔde sua ade) na ɛma nsɛmmisa ne mmuae.']
['Yɛde nhoma ahorow a ɛfa nnuruyɛ mu ɔpepem 35 a ɛwɔ PubMed/Medline ne RefinedWeb mu na efii ase.']
